# 各部分标准句式库

为用户提供选项时的句式模板，按论文部分和句子功能分类。

## Introduction 句式库

### 第1段：大背景

#### 开篇句（疾病重要性）

```
【流行病学角度】
A) [Disease] is one of the most common [conditions] worldwide, 
   affecting approximately [X]% of [population].
   
B) The global prevalence of [disease] has reached [X]%, 
   representing a major public health challenge.
   
C) [Disease] affects an estimated [X] million people globally, 
   with prevalence continuing to rise.

【临床重要性角度】
A) [Disease] is a leading cause of [outcome] in [population].

B) As one of the most significant causes of [outcome], [disease] 
   poses a substantial burden on [healthcare systems/patients].

C) [Disease] remains a major contributor to [morbidity/mortality] 
   among [population].

【趋势角度】
A) The incidence of [disease] has increased dramatically over 
   the past [X] decades.
   
B) [Disease] has emerged as a growing health concern, with 
   prevalence rising from [X]% to [Y]% in recent years.
```

#### 第2-3句（详细背景）

```
【后果/并发症】
A) If left untreated, [disease] can lead to [serious complications], 
   including [具体并发症].
   
B) [Disease] is associated with significant [morbidity/mortality/
   healthcare costs], particularly in [高危人群].

C) The clinical consequences of [disease] include [并发症列表], 
   which can severely impact [quality of life/prognosis].

【现有治疗】
A) Current treatment strategies for [disease] primarily include 
   [治疗方法], which have shown [varying/limited/promising] efficacy.
   
B) Several therapeutic approaches have been developed for [disease], 
   including [方法1], [方法2], and [方法3].
```

### 第2段：研究空白

#### 引出空白

```
【知识空白】
A) However, the [mechanism/relationship/effect] of [X] on [Y] 
   remains poorly understood.
   
B) Despite advances in [领域], limited data are available 
   regarding [具体问题].
   
C) To date, no study has specifically investigated [研究问题].

【争议/不一致】
A) Previous studies examining the association between [X] and [Y] 
   have yielded inconsistent results.
   
B) Whether [factor] is associated with [outcome] remains controversial.

C) The optimal [treatment/approach/strategy] for [condition] has 
   not been established.

【局限性】
A) Most prior studies were limited by [小样本/回顾性设计/短随访等].

B) Previous research has been constrained by [methodological 
   limitations], making it difficult to draw definitive conclusions.

C) Existing evidence is largely derived from [Western populations/
   single centers], limiting generalizability to [other settings].
```

### 第3段：研究目的

```
【目的陈述】
A) Therefore, this study aimed to [investigate/evaluate/assess/
   determine] [研究内容].
   
B) The purpose of this study was to [examine/explore/compare] 
   [研究内容] in [研究人群].
   
C) We conducted this [study type] to [investigate/determine] 
   whether [假设内容].

【附带假设】
A) We hypothesized that [X] would be associated with [Y].

B) Based on [previous evidence/theoretical framework], we 
   hypothesized that [具体假设].
```

---

## Methods 句式库

### Study Design

```
【设计类型】
A) This was a [prospective/retrospective] [cohort/case-control/
   cross-sectional] study conducted at [institution].
   
B) We performed a [single-center/multicenter] [randomized 
   controlled trial/observational study] to [目的].
   
C) This [study type] was conducted at [institution] between 
   [start date] and [end date].

【伦理声明】
A) This study was approved by the Institutional Review Board of 
   [institution] (Approval No. [编号]). Written informed consent 
   was obtained from all participants.
   
B) The study protocol was approved by the Ethics Committee of 
   [institution] (Reference: [编号]). The study was conducted in 
   accordance with the Declaration of Helsinki.
```

### Participants

```
【纳入标准】
A) Patients were eligible for inclusion if they: (1) [标准1]; 
   (2) [标准2]; and (3) [标准3].
   
B) Inclusion criteria were as follows: [criteria list].

C) We included [population] who [met specific criteria].

【排除标准】
A) Patients were excluded if they: (1) [标准1]; (2) [标准2]; 
   or (3) [标准3].
   
B) Exclusion criteria included [criteria list].

【样本量】
A) Sample size was calculated based on [assumptions], with 
   α = 0.05 and power = 80%, yielding a minimum requirement 
   of [N] subjects per group.
   
B) A total of [N] patients who met the eligibility criteria 
   were enrolled.
```

### Statistical Analysis

```
【描述性统计】
A) Continuous variables were expressed as mean ± standard 
   deviation (SD) for normally distributed data, or median 
   (interquartile range, IQR) for non-normally distributed data. 
   Categorical variables were presented as frequencies (percentages).

【组间比较】
A) Comparisons between groups were performed using [t-test/
   Mann-Whitney U test] for continuous variables and [chi-square 
   test/Fisher's exact test] for categorical variables.

【回归分析】
A) [Logistic/Cox/Linear] regression analysis was performed to 
   identify factors associated with [outcome]. Variables with 
   P < 0.1 in univariate analysis were entered into the 
   multivariate model.

【软件声明】
A) All statistical analyses were performed using [software] 
   (version [X], [company], [location]). A two-tailed P value 
   < 0.05 was considered statistically significant.
```

---

## Results 句式库

### 研究流程

```
A) A total of [N] patients were initially screened for eligibility. 
   Of these, [N] were excluded due to [原因]. Finally, [N] patients 
   were included in the analysis.
   
B) During the study period, [N] patients met the inclusion criteria. 
   After excluding [N] patients for [原因], [N] patients remained 
   for the final analysis.
   
C) The patient selection process is shown in Figure 1. Of [N] 
   patients assessed for eligibility, [N] were enrolled.
```

### 基线特征

```
A) Baseline characteristics of the study population are summarized 
   in Table 1.
   
B) The mean age of participants was [X] years (SD: [X]), and 
   [X]% were male.
   
C) There were no significant differences in baseline characteristics 
   between the [group1] and [group2] groups (Table 1).
```

### 主要结局

```
【显著差异】
A) The [outcome] was significantly [higher/lower] in the [group1] 
   group compared with the [group2] group ([data] vs. [data], 
   P = [value]).
   
B) Patients in the [group1] group showed a significantly greater 
   [improvement/reduction] in [outcome] than those in the [group2] 
   group (mean difference: [X], 95% CI: [X-X], P = [value]).

【无显著差异】
A) There was no significant difference in [outcome] between the 
   two groups ([data] vs. [data], P = [value]).
   
B) [Outcome] was similar between groups (P = [value]).
```

### 回归分析结果

```
A) In multivariate analysis, [factor] was independently associated 
   with [outcome] (OR = [X], 95% CI: [X-X], P = [value]), after 
   adjusting for [covariates].
   
B) [Factor] remained a significant predictor of [outcome] in the 
   adjusted model (adjusted OR = [X], 95% CI: [X-X], P = [value]).
```

---

## Discussion 句式库

### 主要发现

```
A) In this [study type], we found that [main finding].

B) The main finding of our study was that [main finding].

C) Our results demonstrated that [main finding].

D) The present study provides evidence that [main finding].
```

### 与文献比较

```
【一致】
A) Our findings are consistent with previous studies showing that 
   [finding].
   
B) In line with [Author et al.], we observed that [finding].

C) This result confirms earlier reports that [finding].

【不一致】
A) In contrast to [Author et al.], we found that [finding]. This 
   discrepancy may be explained by [possible reasons].
   
B) Our results differ from those of [previous study], which 
   reported [their finding]. Several factors may account for this 
   difference, including [reasons].
```

### 机制解释

```
A) Several mechanisms may explain this finding.

B) One possible explanation for our findings is that [mechanism].

C) This observation could be attributed to [biological mechanism].

D) The underlying mechanism may involve [pathway/process].
```

### 局限性

```
A) This study has several limitations that should be acknowledged.

B) First, the [retrospective/cross-sectional] design limits our 
   ability to establish causal relationships.

C) Second, we could not adjust for all potential confounders, 
   such as [unmeasured variables].

D) Third, our findings may not be generalizable to [other 
   populations/settings] due to [reason].

E) Despite these limitations, our study has several strengths, 
   including [strengths].
```

### 结论

```
A) In conclusion, our study demonstrates that [main conclusion].

B) Taken together, these findings suggest that [conclusion with 
   clinical implication].

C) In summary, [brief restatement of key finding]. Further studies 
   are warranted to [future direction].
```
